Clinical trials
Terminated Phase 2 Epilepsy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2021 | 1 |
| 2022 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neurocrine Biosciences | 4 |
| Acorda Therapeutics | 2 |
| Eisai Inc. | 2 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Addex Pharma S.A. | 1 |
| Emory University | 1 |
| Equilibre Biopharmaceuticals B.V. | 1 |
| GlaxoSmithKline | 1 |
| Pfizer | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 20 |
| Seizures | 8 |
| Epilepsies, Partial | 3 |
| Drug Resistant Epilepsy | 2 |
| Epilepsy, Reflex | 2 |
| Epilepsy, Temporal Lobe | 2 |
| Anxiety Disorders | 1 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Epilepsies, Myoclonic | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.